Clinical presentations of steroid modified fungal infection and identification of causative fungus using MALDI TOF ( Matrix assisted laser desorption/Ionisation â?? Time of flight ) technology
Not Applicable
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/06/053876
- Lead Sponsor
- GAYATHRI SANTHOSH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of all age and sex.
2. All the patients with clinical diagnosis of tinea incognito involving the glabrous skin.
Exclusion Criteria
1. Patients with other pre-existing skin disorders.
2. Patients with exclusive Tinea Capitis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study will help us analyse the various clinical presentations & identify the fungal species associated with it. It also shines light on the unregulated sale and unsupervised use of topical steroids and fixed dose combination creams (FDC) containing steroids resulting in a difficult to manage and resistent form of dermatophytosis. <br/ ><br> <br/ ><br>Timepoint: 18 months
- Secondary Outcome Measures
Name Time Method The results will help us find out the treatment resistent fungal species caused by the unregulated use of steroids.Timepoint: 18 months